Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

In a report released today, David Arcaro from Morgan Stanley maintained a Buy rating on PPL (PPL – Research Report), with a price target of ...

Shares of Pembina Pipeline Corp. PPL inched 0.95% higher to C$53.35 Thursday, in what proved to be an all-around favorable trading session for the Canadian market, with the S&P/TSX Composite Index ...

John R. Crockett III, President of a PPL Corp (NYSE:PPL) subsidiary, recently sold 1,589 shares of the company's common stock for approximately $52,627. The transaction, executed under a pre-arranged ...

Bonenberger exercised stock options to acquire 1,483 shares of common stock at a price of $33.51 per share, totaling $49,695.

Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today announced ...

Wells Fargo analyst Neil Kalton has reiterated their bullish stance on NEE stock, giving a Buy rating yesterday.Invest with Confidence: Follow ...

Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...